Registry of Aortic Valve Bioprostheses Established by Catheter to Evaluate 10-Year Survival

What this Trial Is About

This registry focuses on patients who have received aortic valve bioprostheses implanted via catheter through transarterial or transapical routes. It aims to evaluate the overall survival of these patients up to 10 years after implantation. This registry continues previous efforts to assess these valves in patients who were previously considered high risk or unsuitable for traditional surgery, under the oversight of French health authorities. Patients included in this registry have undergone aortic valve replacement using bioprostheses implanted by catheter, following detailed evaluation and approval by cardiac specialists. The registry collects data from all authorized centers in France where this technique is performed, continuing the work of earlier national registries like FRANCE 2. Data collection is standardized and managed by the French Society of Cardiology. Participants are monitored over time through scheduled evaluations to track survival and other health outcomes. The registry links patient data with national health databases to enhance long-term follow-up and ensure comprehensive monitoring up to 10 years. This approach supports understanding of patient prognosis, quality of life, and clinical status following the procedure.

Registry of Aortic Valve Bioprostheses Established by Catheter